After selling off a portion of its diabetes care business last year, Ypsomed is now fully exiting the diabetes care business ...

WEIGHT loss injections have become the holy grail in the fight against obesity, helping people shift the pounds they’ve been ...

(RTTNews) - Halozyme Therapeutics Inc. (HALO) announced that argenx has received U.S. Food and Drug Administration approval of VYVGART Hytrulo prefilled syringe for self-injection (efgartigimod ...

The Amsterdam-based immunology company said the FDA approved a new option for patients to self-inject Vyvgart Hytrulo with a prefilled syringe for certain adult patients with generalized ...

SAN DIEGO, April 10, 2025 /PRNewswire/ -- Halozyme Therapeutics, Inc. (NASDAQ: HALO) (Halozyme) today announced that argenx has received U.S. Food and Drug Administration (FDA) approval of VYVGART ® ...

Argenx (ARGX) announced that the U.S. Food and Drug Administration approved a new option for patients to self-inject VYVGART Hytrulo with a prefilled syringe for the treatment of adult patients ...

Novo counters compounders with direct access channel for Wegovy, price cut for self-paying patients In late February, the FDA formally ended the shortage of semaglutide in the U.S., following ...

McDermott, Will & Emery’s Byron Kalogerou and Meredith Cullen Schwartz say demand in the anti-obesity market and new developments for treating Alzheimer’s disease may spur the life sciences industry ...

Your doctor will explain how to inject Nucala (if you use it at home) or how it’ll be administered to you. If you self-inject Nucala, be sure to follow your doctor’s instructions. The drug is ...

Suzanne Blake is a Newsweek reporter based in New York. Her focus is reporting on consumer and social trends, spanning from retail to restaurants and beyond. She is a graduate of UNC Chapel Hill ...

Semaglutide in particular, whose brand names include Wegovy and Ozempic, showed promise in cutting the risk of conditions that impair memory and thought processes, according to researchers.